Hirokazu Tsubone Selected Research

Equine-Assisted Therapy

1/2019	Effect of hippotherapy on gait symmetry in children with cerebral palsy: A pilot study.
1/2019	Impact of Long-Term Hippotherapy on the Walking Ability of Children With Cerebral Palsy and Quality of Life of Their Caregivers.
2/2018	Impact of serial gait analyses on long-term outcome of hippotherapy in children and adolescents with cerebral palsy.
10/2016	Application of a tri-axial accelerometry-based portable motion recorder for the quantitative assessment of hippotherapy in children and adolescents with cerebral palsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hirokazu Tsubone Research Topics

Disease

4	Cerebral Palsy (Spastic Diplegia) 01/2019 - 10/2016
3	Hypoxia (Hypoxemia) 04/2017 - 11/2005
3	Body Weight (Weight, Body) 04/2015 - 06/2002
3	Bradycardia 11/2012 - 07/2006
3	Vomiting 01/2012 - 07/2006
2	Ileus 10/2019 - 02/2015
2	Brain Injuries (Brain Injury) 04/2017 - 05/2016
2	Cough 05/2013 - 02/2003
2	Premature Cardiac Complexes (Extrasystoles) 11/2012 - 08/2011
2	Atrioventricular Block 11/2012 - 08/2011
2	Ventricular Premature Complexes (Premature Ventricular Contraction) 11/2012 - 08/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2008 - 09/2006
2	Atherosclerosis 04/2005 - 01/2005
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 05/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2014
1	Apnea 05/2013
1	Laryngismus (Laryngospasm) 05/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2013
1	Cardiac Arrhythmias (Arrythmia) 11/2012
1	Colitis 08/2012
1	Enteritis 08/2012
1	Starvation 05/2012
1	Nausea 01/2012
1	Neoplasms (Cancer) 01/2012
1	Vertigo (Positional Vertigo) 07/2007
1	Achlorhydria (Hypochlorhydria) 07/2007
1	Long QT Syndrome 07/2007
1	Hypotension (Low Blood Pressure) 07/2006
1	Hyperventilation 07/2006
1	Necrosis 05/2006
1	Shock 05/2006
1	Right Ventricular Hypertrophy 11/2005
1	Pulmonary Hypertension 11/2005
1	Airway Obstruction (Choking) 02/2003
1	Hypersensitivity (Allergy) 02/2003

Drug/Important Bio-Agent (IBA)

3	EmeticsIBA 01/2012 - 07/2006
3	PolyphenolsIBA 12/2008 - 01/2005
2	Isoflurane FDA LinkGeneric 04/2017 - 05/2016
2	Dextran SulfateIBA 07/2014 - 08/2012
2	Anesthetics (Anesthetic Agents)IBA 05/2013 - 02/2003
2	T-2 Toxin (T 2 Toxin)IBA 01/2013 - 11/2012
2	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 09/2006 - 06/2002
1	mosaprideIBA 10/2019
1	salicylhydroxamic acid (SHAM)IBA 04/2017
1	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 04/2017
1	Neuroprotective AgentsIBA 04/2017
1	Milrinone (Primacor)FDA LinkGeneric 04/2017
1	2-MethoxyestradiolIBA 05/2016
1	Dobutamine FDA LinkGeneric 05/2016
1	LDL CholesterolIBA 04/2015
1	CholesterolIBA 04/2015
1	Cholinesterases (Cholinesterase)IBA 04/2015
1	Alkaline PhosphataseIBA 04/2015
1	TransferasesIBA 04/2015
1	Triglycerides (Triacylglycerol)IBA 04/2015
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 02/2015
1	Irritants (Vesicants)IBA 05/2013
1	Atropine FDA LinkGeneric 11/2012
1	Capsaicin (Zostrix)FDA Link 08/2012
1	AcidsIBA 05/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012
1	Cisplatin (Platino)FDA LinkGeneric 01/2012
1	Copper Sulfate (Sulfate, Copper)FDA Link 01/2012
1	Dihydrotachysterol (AT 10)IBA 08/2011
1	Potassium Channels (Potassium Channel)IBA 07/2007
1	GastrinsIBA 07/2007
1	KCNQ1 Potassium ChannelIBA 07/2007
1	Vehicle Emissions (Emissions, Vehicle)IBA 09/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2006
1	Interleukin-12 (IL 12)IBA 05/2006
1	InterleukinsIBA 05/2006
1	Interleukin-10 (Interleukin 10)IBA 05/2006
1	CytokinesIBA 05/2006
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2005
1	Fluvastatin FDA Link 11/2005
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2005
1	Messenger RNA (mRNA)IBA 11/2005
1	Caveolin 1IBA 11/2005
1	Proteins (Proteins, Gene)FDA Link 11/2005
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2005
1	oxidized low density lipoproteinIBA 04/2005
1	LipidsIBA 01/2005

Therapy/Procedure

4	Equine-Assisted Therapy 01/2019 - 10/2016
2	Anesthesia 02/2003 - 06/2002
1	Drug Therapy (Chemotherapy) 01/2012
1	Ligation 07/2006
1	Denervation 07/2006